Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

BackgroundTramadol is known to cause fewer adverse events (AEs) than other opioids. However, recent research has raised concerns about various safety issues. ObjectiveWe aimed to explore these new AEs related to tramadol using social media and conventional pharmac...

Full description

Bibliographic Details
Main Authors:	Susan Park, So Hyun Choi, Yun-Kyoung Song, Jin-Won Kwon
Format:	Article
Language:	English
Published:	JMIR Publications 2022-01-01
Series:	JMIR Public Health and Surveillance
Online Access:	https://publichealth.jmir.org/2022/1/e33311

Similar Items

Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
by: Yun Li, et al.
Published: (2024-03-01)

Risk Factors for Respiratory Depression Associated with Tramadol Based on the Global Pharmacovigilance Database (VigiBase)
by: Sunny Park, et al.
Published: (2024-02-01)

Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
by: Jinfeng Zhu, et al.
Published: (2024-07-01)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2023-05-01)

Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database
by: Montserrat García, et al.
Published: (2021-06-01)

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
by: Chengzhi Liu, et al.
Published: (2024-12-01)

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system
by: Xianglin Pan, et al.
Published: (2024-07-01)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2022-10-01)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
by: Sandra Rodríguez, et al.
Published: (2020-08-01)

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
by: Francesca Scicchitano, et al.
Published: (2012-01-01)

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
by: Jingrong Yang, et al.
Published: (2025-01-01)

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
by: Kaibin Niu, et al.
Published: (2024-06-01)

A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib
by: Yi Yin, et al.
Published: (2024-11-01)

A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam
by: Weizhen He, et al.
Published: (2024-01-01)

A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
by: Yiming Qi, et al.
Published: (2024-05-01)

Analysis of adverse drug reactions reported to national pharmacovigilance center of Bhutan
by: Pelden Chejor, et al.
Published: (2021-06-01)

Automatic tool for the reconciliation of serious adverse events for pharmacovigilance: design and implementation of Reconciliaid
by: Sara Contu, et al.
Published: (2025-01-01)

The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review
by: Su Golder, et al.
Published: (2024-09-01)

Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
by: Long He, et al.
Published: (2024-07-01)

Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS
by: Meng Li, et al.
Published: (2022-11-01)

Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database
by: Rita Karam, et al.
Published: (2024-10-01)

Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database
by: Zhengkang Su, et al.
Published: (2024-11-01)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
by: Pan Ma, et al.
Published: (2022-11-01)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
by: Jung-Yoon Choi, et al.
Published: (2021-05-01)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
by: Xusheng Zhang, et al.
Published: (2024-07-01)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax.
by: Yang Yang, et al.
Published: (2022-01-01)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
by: Menglin Guo, et al.
Published: (2022-11-01)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
by: Yanchao Yin, et al.
Published: (2022-11-01)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
by: Yang Yang, et al.
Published: (2022-01-01)

Pharmacovigilance and reporting adverse drug reactions.
by: Isa NM,
Published: (2014)

Adverse Reactions to Intravenous Immunoglobulin Therapy: An Analysis of the Russian National Pharmacovigilance Database
by: A. V. Nechaev, et al.
Published: (2024-12-01)

Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
by: Weidong Zhang, et al.
Published: (2025-01-01)

Ocular adverse events associated with antibody-drug conjugates: a comprehensive pharmacovigilance analysis
by: Heng Chen, et al.
Published: (2024-12-01)

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
by: Runan Fang, et al.
Published: (2024-11-01)

A realworld pharmacovigilance study of trazodone based on the FDA adverse event reporting system
by: Yong Yu, et al.
Published: (2025-02-01)

Cardiovascular adverse events associated with targeted therapies for multiple myeloma: a pharmacovigilance study
by: Yanli Zhang, et al.
Published: (2024-09-01)

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis
by: Yuanqiong Duan, et al.
Published: (2024-10-01)

Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database
by: Ruixue Liu, et al.
Published: (2024-06-01)

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
by: Dehua Zhao, et al.
Published: (2023-09-01)

Tramadol-induced hypoglycemia: An unusual adverse effect
by: Subramanian Senthilkumaran, et al.
Published: (2017-01-01)